NantKwest Inc.

NantKwest Inc.
Stock Exchange NASDAQ Stock Market
EPS
$1.09
Market Cap
$108.54 M
Shares Outstanding
98.67 M
Public Float
9.14 M

Profile

Address
3530 John Hopkins Court
San Diego California 92121
United States
Employees -
Website http://www.nantkwest.com
Updated 07/08/2019
NantKwest, Inc. engages in the development of immunotherapies with a focus on harnessing the power of the innate immune system. It uses natural killer cells to treat cancer, infectious diseases, and inflammatory diseases. The firm operates through the following geographical segments: United States; Europe; and Other Non-U.

Financials

View All
Created with Highcharts 5.0.14NantKwest Inc.Net Income. Fiscal year is January-December. All values USD Thousands.2 0472 0476 1856 185236 876236 876120 809120 80996 42396 42396 22696 226201320142015201620172018050k100k150k200k250k
Created with Highcharts 5.0.14NantKwest Inc.Sales/Revenue. Fiscal year is January-December. All values USD Thousands.6006006416412362364444454547472013201420152016201720180200400600800

Patrick Soon-Shiong
Chairman & Chief Executive Officer
Barry J. Simon
President, Director & Chief Administrative Officer